Global Positron Emission tomography Market
Global Positron Emission tomography Market

Positron Emission tomography Comprehensive Study by Type (PET-CT, PET-MR, Other), Application (Cancer Treatment, Neurology, Cardiology), PET Scanner (Full Ring PET Scanners, Partial Ring PET Scanners), End User (Hospitals, Diagnostic Centers, Other), PET Scans (PET f-18 FDG Scan, Cardiac PET Scan, PET/CT Scan) Players and Region - Global Market Outlook to 2024

Positron Emission tomography Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Feb 2020 Edition 200 Pages 187 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Market Snapshot:
Positron emission tomography (PET) is a type of nuclear medicine procedure that measures metabolic activity of the cells of body tissues. PET is actually a combination of nuclear medicine and biochemical analysis. A positron emission tomography (PET) scan is an imaging test that helps reveal how your tissues and organs are functioning. A PET scan uses a radioactive drug (tracer) to show this activity. A PET Scan (or Positron Emission Tomography) is a non-invasive, diagnostic examination that finds information about the activity of different parts of the body.

Market Drivers
  • Increasing Demand for PET Analysis in Radio Pharmaceuticals
  • Integration of X-ray Tomography (CT) into PET

Market Trend
  • Oncology is Expected to Hold the Largest Share of the Positron Emission Tomography Market

Restraints
  • Shorter Half-life of Radioisotopes
  • Stringent Regulatory Guidelines

Opportunities
Technological Advancements in Pet Imaging for Oncology and Advanced Diagnostics Applications

Players Covered in the Study are:
Gamma Medica Inc. (United States), GE Healthcare (United States), Neusoft Medical Systems (China), Oncovision (Spain), Koninklijke Philips NV (Netherlands), Positron Corporation (United States), Siemens AG (Germany), Toshiba (Japan), Hitachi (Japan) and United Imaging (China)

The Global Positron Emission tomography market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.


Report Objectives / Segmentation Covered
By Type
  • PET-CT
  • PET-MR
  • Other
By Application
  • Cancer Treatment
  • Neurology
  • Cardiology
By PET Scanner
  • Full Ring PET Scanners
  • Partial Ring PET Scanners

By End User
  • Hospitals
  • Diagnostic Centers
  • Other

By PET Scans
  • PET f-18 FDG Scan
  • Cardiac PET Scan
  • PET/CT Scan

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for PET Analysis in Radio Pharmaceuticals
      • 3.2.2. Integration of X-ray Tomography (CT) into PET
    • 3.3. Market Challenges
      • 3.3.1. Harmful for the People with Allergies and Other Health Conditions
      • 3.3.2. Harmful for the Ladies who are pregnant
    • 3.4. Market Trends
      • 3.4.1. Oncology is Expected to Hold the Largest Share of the Positron Emission Tomography Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Positron Emission tomography, by Type, Application, PET Scanner, End User, PET Scans and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Positron Emission tomography (Value)
      • 5.2.1. Global Positron Emission tomography by: Type (Value)
        • 5.2.1.1. PET-CT
        • 5.2.1.2. PET-MR
        • 5.2.1.3. Other
      • 5.2.2. Global Positron Emission tomography by: Application (Value)
        • 5.2.2.1. Cancer Treatment
        • 5.2.2.2. Neurology
        • 5.2.2.3. Cardiology
      • 5.2.3. Global Positron Emission tomography by: PET Scanner (Value)
        • 5.2.3.1. Full Ring PET Scanners
        • 5.2.3.2. Partial Ring PET Scanners
      • 5.2.4. Global Positron Emission tomography by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Other
      • 5.2.5. Global Positron Emission tomography by: PET Scans (Value)
        • 5.2.5.1. PET f-18 FDG Scan
        • 5.2.5.2. Cardiac PET Scan
        • 5.2.5.3. PET/CT Scan
      • 5.2.6. Global Positron Emission tomography Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Positron Emission tomography: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Gamma Medica Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GE Healthcare (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Neusoft Medical Systems (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Oncovision (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips NV (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Positron Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Toshiba (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hitachi (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. United Imaging (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Positron Emission tomography Sale, by Type, Application, PET Scanner, End User, PET Scans and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Positron Emission tomography (Value)
      • 7.2.1. Global Positron Emission tomography by: Type (Value)
        • 7.2.1.1. PET-CT
        • 7.2.1.2. PET-MR
        • 7.2.1.3. Other
      • 7.2.2. Global Positron Emission tomography by: Application (Value)
        • 7.2.2.1. Cancer Treatment
        • 7.2.2.2. Neurology
        • 7.2.2.3. Cardiology
      • 7.2.3. Global Positron Emission tomography by: PET Scanner (Value)
        • 7.2.3.1. Full Ring PET Scanners
        • 7.2.3.2. Partial Ring PET Scanners
      • 7.2.4. Global Positron Emission tomography by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Other
      • 7.2.5. Global Positron Emission tomography by: PET Scans (Value)
        • 7.2.5.1. PET f-18 FDG Scan
        • 7.2.5.2. Cardiac PET Scan
        • 7.2.5.3. PET/CT Scan
      • 7.2.6. Global Positron Emission tomography Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Positron Emission tomography: by Type(USD Million)
  • Table 2. Positron Emission tomography PET-CT , by Region USD Million (2013-2018)
  • Table 3. Positron Emission tomography PET-MR , by Region USD Million (2013-2018)
  • Table 4. Positron Emission tomography Other , by Region USD Million (2013-2018)
  • Table 5. Positron Emission tomography: by Application(USD Million)
  • Table 6. Positron Emission tomography Cancer Treatment , by Region USD Million (2013-2018)
  • Table 7. Positron Emission tomography Neurology , by Region USD Million (2013-2018)
  • Table 8. Positron Emission tomography Cardiology , by Region USD Million (2013-2018)
  • Table 9. Positron Emission tomography: by PET Scanner(USD Million)
  • Table 10. Positron Emission tomography Full Ring PET Scanners , by Region USD Million (2013-2018)
  • Table 11. Positron Emission tomography Partial Ring PET Scanners , by Region USD Million (2013-2018)
  • Table 12. Positron Emission tomography: by End User(USD Million)
  • Table 13. Positron Emission tomography Hospitals , by Region USD Million (2013-2018)
  • Table 14. Positron Emission tomography Diagnostic Centers , by Region USD Million (2013-2018)
  • Table 15. Positron Emission tomography Other , by Region USD Million (2013-2018)
  • Table 16. Positron Emission tomography: by PET Scans(USD Million)
  • Table 17. Positron Emission tomography PET f-18 FDG Scan , by Region USD Million (2013-2018)
  • Table 18. Positron Emission tomography Cardiac PET Scan , by Region USD Million (2013-2018)
  • Table 19. Positron Emission tomography PET/CT Scan , by Region USD Million (2013-2018)
  • Table 20. South America Positron Emission tomography, by Country USD Million (2013-2018)
  • Table 21. South America Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 22. South America Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 23. South America Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 24. South America Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 25. South America Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 26. Brazil Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 27. Brazil Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 28. Brazil Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 29. Brazil Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 30. Brazil Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 31. Argentina Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 32. Argentina Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 33. Argentina Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 34. Argentina Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 35. Argentina Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 36. Rest of South America Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 37. Rest of South America Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 38. Rest of South America Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 39. Rest of South America Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 40. Rest of South America Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 41. Asia Pacific Positron Emission tomography, by Country USD Million (2013-2018)
  • Table 42. Asia Pacific Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 43. Asia Pacific Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 44. Asia Pacific Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 45. Asia Pacific Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 46. Asia Pacific Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 47. China Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 48. China Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 49. China Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 50. China Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 51. China Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 52. Japan Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 53. Japan Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 54. Japan Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 55. Japan Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 56. Japan Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 57. India Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 58. India Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 59. India Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 60. India Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 61. India Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 62. South Korea Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 63. South Korea Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 64. South Korea Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 65. South Korea Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 66. South Korea Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 67. Taiwan Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 68. Taiwan Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 69. Taiwan Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 70. Taiwan Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 71. Taiwan Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 72. Australia Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 73. Australia Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 74. Australia Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 75. Australia Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 76. Australia Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 77. Rest of Asia-Pacific Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 78. Rest of Asia-Pacific Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 79. Rest of Asia-Pacific Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 80. Rest of Asia-Pacific Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 81. Rest of Asia-Pacific Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 82. Europe Positron Emission tomography, by Country USD Million (2013-2018)
  • Table 83. Europe Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 84. Europe Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 85. Europe Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 86. Europe Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 87. Europe Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 88. Germany Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 89. Germany Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 90. Germany Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 91. Germany Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 92. Germany Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 93. France Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 94. France Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 95. France Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 96. France Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 97. France Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 98. Italy Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 99. Italy Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 100. Italy Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 101. Italy Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 102. Italy Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 103. United Kingdom Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 104. United Kingdom Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 105. United Kingdom Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 106. United Kingdom Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 107. United Kingdom Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 108. Netherlands Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 109. Netherlands Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 110. Netherlands Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 111. Netherlands Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 112. Netherlands Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 113. Rest of Europe Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 114. Rest of Europe Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 115. Rest of Europe Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 116. Rest of Europe Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 117. Rest of Europe Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 118. MEA Positron Emission tomography, by Country USD Million (2013-2018)
  • Table 119. MEA Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 120. MEA Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 121. MEA Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 122. MEA Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 123. MEA Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 124. Middle East Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 125. Middle East Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 126. Middle East Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 127. Middle East Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 128. Middle East Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 129. Africa Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 130. Africa Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 131. Africa Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 132. Africa Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 133. Africa Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 134. North America Positron Emission tomography, by Country USD Million (2013-2018)
  • Table 135. North America Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 136. North America Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 137. North America Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 138. North America Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 139. North America Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 140. United States Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 141. United States Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 142. United States Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 143. United States Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 144. United States Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 145. Canada Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 146. Canada Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 147. Canada Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 148. Canada Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 149. Canada Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 150. Mexico Positron Emission tomography, by Type USD Million (2013-2018)
  • Table 151. Mexico Positron Emission tomography, by Application USD Million (2013-2018)
  • Table 152. Mexico Positron Emission tomography, by PET Scanner USD Million (2013-2018)
  • Table 153. Mexico Positron Emission tomography, by End User USD Million (2013-2018)
  • Table 154. Mexico Positron Emission tomography, by PET Scans USD Million (2013-2018)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Positron Emission tomography: by Type(USD Million)
  • Table 166. Positron Emission tomography PET-CT , by Region USD Million (2019-2024)
  • Table 167. Positron Emission tomography PET-MR , by Region USD Million (2019-2024)
  • Table 168. Positron Emission tomography Other , by Region USD Million (2019-2024)
  • Table 169. Positron Emission tomography: by Application(USD Million)
  • Table 170. Positron Emission tomography Cancer Treatment , by Region USD Million (2019-2024)
  • Table 171. Positron Emission tomography Neurology , by Region USD Million (2019-2024)
  • Table 172. Positron Emission tomography Cardiology , by Region USD Million (2019-2024)
  • Table 173. Positron Emission tomography: by PET Scanner(USD Million)
  • Table 174. Positron Emission tomography Full Ring PET Scanners , by Region USD Million (2019-2024)
  • Table 175. Positron Emission tomography Partial Ring PET Scanners , by Region USD Million (2019-2024)
  • Table 176. Positron Emission tomography: by End User(USD Million)
  • Table 177. Positron Emission tomography Hospitals , by Region USD Million (2019-2024)
  • Table 178. Positron Emission tomography Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 179. Positron Emission tomography Other , by Region USD Million (2019-2024)
  • Table 180. Positron Emission tomography: by PET Scans(USD Million)
  • Table 181. Positron Emission tomography PET f-18 FDG Scan , by Region USD Million (2019-2024)
  • Table 182. Positron Emission tomography Cardiac PET Scan , by Region USD Million (2019-2024)
  • Table 183. Positron Emission tomography PET/CT Scan , by Region USD Million (2019-2024)
  • Table 184. South America Positron Emission tomography, by Country USD Million (2019-2024)
  • Table 185. South America Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 186. South America Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 187. South America Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 188. South America Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 189. South America Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 190. Brazil Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 191. Brazil Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 192. Brazil Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 193. Brazil Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 194. Brazil Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 195. Argentina Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 196. Argentina Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 197. Argentina Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 198. Argentina Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 199. Argentina Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 200. Rest of South America Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 201. Rest of South America Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 202. Rest of South America Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 203. Rest of South America Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 204. Rest of South America Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 205. Asia Pacific Positron Emission tomography, by Country USD Million (2019-2024)
  • Table 206. Asia Pacific Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 207. Asia Pacific Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 208. Asia Pacific Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 209. Asia Pacific Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 210. Asia Pacific Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 211. China Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 212. China Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 213. China Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 214. China Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 215. China Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 216. Japan Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 217. Japan Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 218. Japan Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 219. Japan Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 220. Japan Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 221. India Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 222. India Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 223. India Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 224. India Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 225. India Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 226. South Korea Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 227. South Korea Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 228. South Korea Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 229. South Korea Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 230. South Korea Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 231. Taiwan Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 232. Taiwan Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 233. Taiwan Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 234. Taiwan Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 235. Taiwan Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 236. Australia Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 237. Australia Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 238. Australia Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 239. Australia Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 240. Australia Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 241. Rest of Asia-Pacific Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 242. Rest of Asia-Pacific Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 243. Rest of Asia-Pacific Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 244. Rest of Asia-Pacific Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 245. Rest of Asia-Pacific Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 246. Europe Positron Emission tomography, by Country USD Million (2019-2024)
  • Table 247. Europe Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 248. Europe Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 249. Europe Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 250. Europe Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 251. Europe Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 252. Germany Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 253. Germany Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 254. Germany Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 255. Germany Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 256. Germany Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 257. France Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 258. France Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 259. France Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 260. France Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 261. France Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 262. Italy Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 263. Italy Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 264. Italy Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 265. Italy Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 266. Italy Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 267. United Kingdom Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 268. United Kingdom Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 269. United Kingdom Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 270. United Kingdom Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 271. United Kingdom Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 272. Netherlands Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 273. Netherlands Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 274. Netherlands Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 275. Netherlands Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 276. Netherlands Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 277. Rest of Europe Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 278. Rest of Europe Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 279. Rest of Europe Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 280. Rest of Europe Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 281. Rest of Europe Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 282. MEA Positron Emission tomography, by Country USD Million (2019-2024)
  • Table 283. MEA Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 284. MEA Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 285. MEA Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 286. MEA Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 287. MEA Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 288. Middle East Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 289. Middle East Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 290. Middle East Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 291. Middle East Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 292. Middle East Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 293. Africa Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 294. Africa Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 295. Africa Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 296. Africa Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 297. Africa Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 298. North America Positron Emission tomography, by Country USD Million (2019-2024)
  • Table 299. North America Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 300. North America Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 301. North America Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 302. North America Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 303. North America Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 304. United States Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 305. United States Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 306. United States Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 307. United States Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 308. United States Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 309. Canada Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 310. Canada Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 311. Canada Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 312. Canada Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 313. Canada Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 314. Mexico Positron Emission tomography, by Type USD Million (2019-2024)
  • Table 315. Mexico Positron Emission tomography, by Application USD Million (2019-2024)
  • Table 316. Mexico Positron Emission tomography, by PET Scanner USD Million (2019-2024)
  • Table 317. Mexico Positron Emission tomography, by End User USD Million (2019-2024)
  • Table 318. Mexico Positron Emission tomography, by PET Scans USD Million (2019-2024)
  • Table 319. Research Programs/Design for This Report
  • Table 320. Key Data Information from Secondary Sources
  • Table 321. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Positron Emission tomography: by Type USD Million (2013-2018)
  • Figure 5. Global Positron Emission tomography: by Application USD Million (2013-2018)
  • Figure 6. Global Positron Emission tomography: by PET Scanner USD Million (2013-2018)
  • Figure 7. Global Positron Emission tomography: by End User USD Million (2013-2018)
  • Figure 8. Global Positron Emission tomography: by PET Scans USD Million (2013-2018)
  • Figure 9. South America Positron Emission tomography Share (%), by Country
  • Figure 10. Asia Pacific Positron Emission tomography Share (%), by Country
  • Figure 11. Europe Positron Emission tomography Share (%), by Country
  • Figure 12. MEA Positron Emission tomography Share (%), by Country
  • Figure 13. North America Positron Emission tomography Share (%), by Country
  • Figure 14. Global Positron Emission tomography share by Players 2018 (%)
  • Figure 15. Global Positron Emission tomography share by Players (Top 3) 2018(%)
  • Figure 16. Global Positron Emission tomography share by Players (Top 5) 2018(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Gamma Medica Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Gamma Medica Inc. (United States) Revenue: by Geography 2018
  • Figure 20. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 21. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 22. Neusoft Medical Systems (China) Revenue, Net Income and Gross profit
  • Figure 23. Neusoft Medical Systems (China) Revenue: by Geography 2018
  • Figure 24. Oncovision (Spain) Revenue, Net Income and Gross profit
  • Figure 25. Oncovision (Spain) Revenue: by Geography 2018
  • Figure 26. Koninklijke Philips NV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 27. Koninklijke Philips NV (Netherlands) Revenue: by Geography 2018
  • Figure 28. Positron Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Positron Corporation (United States) Revenue: by Geography 2018
  • Figure 30. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Siemens AG (Germany) Revenue: by Geography 2018
  • Figure 32. Toshiba (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Toshiba (Japan) Revenue: by Geography 2018
  • Figure 34. Hitachi (Japan) Revenue, Net Income and Gross profit
  • Figure 35. Hitachi (Japan) Revenue: by Geography 2018
  • Figure 36. United Imaging (China) Revenue, Net Income and Gross profit
  • Figure 37. United Imaging (China) Revenue: by Geography 2018
  • Figure 38. Global Positron Emission tomography: by Type USD Million (2019-2024)
  • Figure 39. Global Positron Emission tomography: by Application USD Million (2019-2024)
  • Figure 40. Global Positron Emission tomography: by PET Scanner USD Million (2019-2024)
  • Figure 41. Global Positron Emission tomography: by End User USD Million (2019-2024)
  • Figure 42. Global Positron Emission tomography: by PET Scans USD Million (2019-2024)
  • Figure 43. South America Positron Emission tomography Share (%), by Country
  • Figure 44. Asia Pacific Positron Emission tomography Share (%), by Country
  • Figure 45. Europe Positron Emission tomography Share (%), by Country
  • Figure 46. MEA Positron Emission tomography Share (%), by Country
  • Figure 47. North America Positron Emission tomography Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Gamma Medica Inc. (United States)
  • GE Healthcare (United States)
  • Neusoft Medical Systems (China)
  • Oncovision (Spain)
  • Koninklijke Philips NV (Netherlands)
  • Positron Corporation (United States)
  • Siemens AG (Germany)
  • Toshiba (Japan)
  • Hitachi (Japan)
  • United Imaging (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation